{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T21:55:19Z","timestamp":1793656519663,"version":"4.5.1"},"reference-count":57,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2002,6,1]],"date-time":"2002-06-01T00:00:00Z","timestamp":1022889600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Curr Oncol Rep"],"published-print":{"date-parts":[[2002,6]]},"DOI":"10.1007\/s11912-002-0023-1","type":"journal-article","created":{"date-parts":[[2007,6,1]],"date-time":"2007-06-01T14:47:56Z","timestamp":1180709276000},"page":"250-255","source":"Crossref","is-referenced-by-count":254,"title":["The role of C-reactive protein as a prognostic indicator in advanced cancer"],"prefix":"10.1007","volume":"4","author":[{"given":"Fade Aziz","family":"Mahmoud","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nilo I.","family":"Rivera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"23_CR1","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/S0885-3924(00)00169-X","volume":"20","author":"P Geissbuhler","year":"2000","unstructured":"Geissbuhler P, Mermillod B, Rapin CH: Elevated serum vitamin B12 levels associated with CRP as a predictive factor of mortality in palliative care cancer patients: a prospective study over five years. J Pain Symptom Manage 2000, 20:93\u2013103. This interesting study indicates that an elevated serum B12 level is a predictive factor for mortality, independent of CRP and other factors, in palliative care.","journal-title":"J Pain Symptom Manage"},{"key":"23_CR2","doi-asserted-by":"crossref","first-page":"274","DOI":"10.3109\/07853890009011772","volume":"32","author":"TW Clos Du","year":"2000","unstructured":"Du Clos TW: Function of C-reactive protein. Ann Med 2000, 32:274\u2013278.","journal-title":"Ann Med"},{"key":"23_CR3","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1097\/00006454-199708000-00003","volume":"16","author":"DL Jaye","year":"1997","unstructured":"Jaye DL, Waites KB: Clinical applications of C-reactive protein in pediatrics. Pediatr Infect Dis J 1997, 16:735\u2013746.","journal-title":"Pediatr Infect Dis J"},{"key":"23_CR4","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1161\/01.CIR.104.9.974","volume":"104","author":"ET Yeh","year":"2001","unstructured":"Yeh ET, Anderson HV, Pasceri V, Willerson JT: C-reactive protein: linking inflammation to cardiovascular complications. Circulation 2001, 104:974\u2013975. This is an interesting article discussing the role of inflammation and CRP as predisposing to cardiovascular events.","journal-title":"Circulation"},{"key":"23_CR5","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1056\/NEJM199902113400607","volume":"340","author":"C Gabay","year":"1999","unstructured":"Gabay C, Kushner I: Acute-phase proteins and other systemic responses to inflammation. N Engl J Med 1999, 340:448\u2013454.","journal-title":"N Engl J Med"},{"key":"23_CR6","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/S0025-7125(05)70211-X","volume":"84","author":"DA Morrow","year":"2000","unstructured":"Morrow DA, Ridker PM: C-reactive protein, inflammation, and coronary risk. Med Clin North Am 2000, 84:149\u2013161.","journal-title":"Med Clin North Am"},{"key":"23_CR7","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1161\/01.STR.32.4.917","volume":"32","author":"M Napoli Di","year":"2001","unstructured":"Di Napoli M, Papa F, Bocola V: C-reactive protein in ischemic stroke: an independent prognostic factor. Stroke 2001, 32:917\u2013924.","journal-title":"Stroke"},{"key":"23_CR8","doi-asserted-by":"crossref","first-page":"535","DOI":"10.3949\/ccjm.68.6.535","volume":"68","author":"I Kushner","year":"2001","unstructured":"Kushner I: C-reactive protein elevation can be caused by conditions other than inflammation and may reflect biologic aging. Cleve Clin J Med 2001, 68:535\u2013537. s is an excellent article discussing the role of CRP as a predictor for both biologic aging and poor prognosis in many conditions.","journal-title":"Cleve Clin J Med"},{"key":"23_CR9","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1002\/bjs.1800820233","volume":"82","author":"T Preston","year":"1995","unstructured":"Preston T, Fearon KC, McMillan DC, et al.: Effect of ibuprofen on the acute-phase response and protein metabolism in patients with cancer and weight loss. Br J Surg 1995, 82:229\u2013234.","journal-title":"Br J Surg"},{"key":"23_CR10","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1038\/sj.bjc.6690077","volume":"79","author":"DC McMillan","year":"1999","unstructured":"McMillan DC, Wigmore SJ, Fearon KC, et al.: A prospective randomized study of megestrol acetate and ibuprofen in gastrointestinal cancer patients with weight loss. Br J Cancer 1999, 79:495\u2013500. s is an outstanding study comparing the combination of megestrol acetate and placebo with megestrol acetate and ibuprofen in the treatment of weight loss in patients with gastrointestinal cancer.","journal-title":"Br J Cancer"},{"key":"23_CR11","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/0167-5699(92)90057-E","volume":"13","author":"A Falus","year":"1992","unstructured":"Falus A, Meretey K: Histamine: an early messenger in inflammatory and immune reactions. Immunol Today 1992, 13:154\u2013156.","journal-title":"Immunol Today"},{"key":"23_CR12","first-page":"138","volume":"181","author":"LA Rasmussen","year":"1995","unstructured":"Rasmussen LA, Nielsen HJ, Sorensen S, et al.: Ranitidine reduces postoperative interleukin-6 induced C-reactive protein synthesis. J Am Coll Surg 1995, 181:138\u2013144.","journal-title":"J Am Coll Surg"},{"key":"23_CR13","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1182\/blood.V85.3.765.bloodjournal853765","volume":"85","author":"TT Pelliniemi","year":"1995","unstructured":"Pelliniemi TT, Irjala K, Mattila K, et al.: Immunoreactive interleukin-6 and acute phase proteins as prognostic factors in multiple myeloma. Finnish Leukemia Group. Blood 1995, 85:765\u2013771.","journal-title":"Blood"},{"key":"23_CR14","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1038\/bjc.1994.175","volume":"69","author":"E Tartour","year":"1994","unstructured":"Tartour E, Dorval T, Mosseri V, et al.: Serum interleukin 6 and C-reactive protein levels correlate with resistance to IL-2 therapy and poor survival in melanoma patients. Br J Cancer 1994, 69:911\u2013913.","journal-title":"Br J Cancer"},{"key":"23_CR15","doi-asserted-by":"crossref","first-page":"351","DOI":"10.3109\/10428199809059228","volume":"31","author":"E Legouffe","year":"1998","unstructured":"Legouffe E, Rodriguez C, Picot MC, et al.: C-reactive protein serum level is a valuable and simple prognostic marker in non Hodgkin\u2019s lymphoma. Leuk Lymphoma 1998, 31:351\u2013357.","journal-title":"Leuk Lymphoma"},{"key":"23_CR16","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/S0301-2115(98)00227-9","volume":"82","author":"J Kodama","year":"1999","unstructured":"Kodama J, Miyagi Y, Seki N, et al.: Serum C-reactive protein as a prognostic factor in patients with epithelial ovarian cancer. Eur J Obstet Gynecol Reprod Biol 1999, 82:107\u2013110. is an interesting study about the role of CRP in predicting survival.","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"23_CR17","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1038\/bjc.1995.71","volume":"71","author":"G Scambia","year":"1995","unstructured":"Scambia G, Testa U, Benedetti PP, et al.: Prognostic significance of interleukin 6 serum levels in patients with ovarian cancer. Br J Cancer 1995, 71:354\u2013356.","journal-title":"Br J Cancer"},{"key":"23_CR18","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1002\/1097-0142(19951015)76:8<1435::AID-CNCR2820760821>3.0.CO;2-Y","volume":"76","author":"B Ljungberg","year":"1995","unstructured":"Ljungberg B, Grankvist K, Rasmuson T: Serum acute phase reactants and prognosis in renal cell carcinoma. Cancer 1995, 76:1435\u20131439.","journal-title":"Cancer"},{"key":"23_CR19","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1046\/j.1365-2168.2001.01882-4.x","volume":"88","author":"A Huang","year":"2001","unstructured":"Huang A, Tsavellas G: Acute-phase protein, survival and tumour recurrence in patients with colorectal cancer. Br J Surg 2001, 88:1128.","journal-title":"Br J Surg"},{"key":"23_CR20","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1207\/S15327914NC3701_4","volume":"37","author":"P O\u2019Gorman","year":"2000","unstructured":"O\u2019Gorman P, McMillan DC, McArdle CS: Prognostic factors in advanced gastrointestinal cancer patients with weight loss. Nutr Cancer 2000, 37:36\u201340.","journal-title":"Nutr Cancer"},{"key":"23_CR21","doi-asserted-by":"crossref","first-page":"2077","DOI":"10.1002\/1097-0142(19950415)75:8<2077::AID-CNCR2820750808>3.0.CO;2-9","volume":"75","author":"JS Falconer","year":"1995","unstructured":"Falconer JS, Fearon KC, Ross JA, et al.: Acute-phase protein response and survival duration of patients with pancreatic cancer. Cancer 1995, 75:2077\u20132082.","journal-title":"Cancer"},{"key":"23_CR22","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1042\/cs0960083","volume":"96","author":"MD Barber","year":"1999","unstructured":"Barber MD, Fearon KC, Ross JA: Relationship of serum levels of interleukin-6, soluble interleukin-6 receptor and tumour necrosis factor receptors to the acute-phase protein response in advanced pancreatic cancer. Clin Sci 1999, 96:83\u201387.","journal-title":"Clin Sci"},{"key":"23_CR23","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/S0002-9610(98)00204-9","volume":"176","author":"T Nozoe","year":"1998","unstructured":"Nozoe T, Matsumata T, Kitamura M, Sugimachi K: Significance of preoperative elevation of serum C-reactive protein as an indicator for prognosis in colorectal cancer. Am J Surg 1998, 176:335\u2013338.","journal-title":"Am J Surg"},{"key":"23_CR24","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/S0090-4295(01)01165-7","volume":"58","author":"Y Miyata","year":"2001","unstructured":"Miyata Y, Koga S, Nishikido M, et al.: Predictive values of acute phase reactants, basic fetoprotein, and immunosuppressive acidic protein for staging and survival in renal cell carcinoma. Urology 2001, 58:161\u2013164.","journal-title":"Urology"},{"key":"23_CR25","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1182\/blood.V88.3.838.838","volume":"88","author":"DH Vesole","year":"1996","unstructured":"Vesole DH, Tricot G, Jagannath S, et al.: Autotransplants in multiple myeloma: what have we learned? Blood 1996, 88:838\u2013847.","journal-title":"Blood"},{"key":"23_CR26","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1182\/blood.V80.3.733.733","volume":"80","author":"R Bataille","year":"1992","unstructured":"Bataille R, Boccadoro M, Klein B, et al.: C-reactive protein and beta-2 microglobulin produce a simple and powerful myeloma staging system. Blood 1992, 80:733\u2013737.","journal-title":"Blood"},{"key":"23_CR27","first-page":"275","volume":"5","author":"JC Mestries","year":"1994","unstructured":"Mestries JC, Kruithof EK, Gascon MP, et al.: In vivo modulation of coagulation and fibrinolysis by recombinant glycosylated human interleukin-6 in baboons. Eur Cytokine Netw 1994, 5:275\u2013281.","journal-title":"Eur Cytokine Netw"},{"key":"23_CR28","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1182\/blood.V82.2.513.513","volume":"82","author":"J Cermak","year":"1993","unstructured":"Cermak J, Key NS, Bach RR, et al.: C-reactive protein induces human peripheral blood monocytes to synthesize tissue factor. Blood 1993, 82:513\u2013520.","journal-title":"Blood"},{"key":"23_CR29","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1016\/S0002-9343(99)00066-2","volume":"106","author":"TB Harris","year":"1999","unstructured":"Harris TB, Ferrucci L, Tracy RP, et al.: Associations of elevated interleukin-6 and C-reactive protein levels with mortality in the elderly. Am J Med 1999, 106:506\u2013512.","journal-title":"Am J Med"},{"key":"23_CR30","first-page":"29","volume":"44","author":"PA Baeuerle","year":"1996","unstructured":"Baeuerle PA, Rupec RA, Pahl HL: Reactive oxygen intermediates as second messengers of a general pathogen response. Pathol Biol 1996, 44:29\u201335.","journal-title":"Pathol Biol"},{"key":"23_CR31","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1200\/JCO.1994.12.1.213","volume":"12","author":"KA Nelson","year":"1994","unstructured":"Nelson KA, Walsh D, Sheehan FA: The cancer anorexiacachexia syndrome. J Clin Oncol 1994, 12:213\u2013225.","journal-title":"J Clin Oncol"},{"key":"23_CR32","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1007\/s005200050281","volume":"8","author":"D Walsh","year":"2000","unstructured":"Walsh D, Donnelly S, Rybicki L: The symptoms of advanced cancer: relationship to age, gender, and performance status in 1,000 patients. Support Care Cancer 2000, 8:175\u2013179. s is an excellent comprehensive prospective analysis of symptoms in 1000 patients with advanced cancer.","journal-title":"Support Care Cancer"},{"key":"23_CR33","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1172\/JCI115767","volume":"89","author":"G Strassmann","year":"1992","unstructured":"Strassmann G, Fong M, Kenney JS, Jacob CO: Evidence for the involvement of interleukin 6 in experimental cancer cachexia. J Clin Invest 1992, 89:1681\u20131684.","journal-title":"J Clin Invest"},{"key":"23_CR34","doi-asserted-by":"crossref","first-page":"243S","DOI":"10.1093\/jn\/129.1.243S","volume":"129","author":"MJ Tisdale","year":"1999","unstructured":"Tisdale MJ: Wasting in cancer. J Nutr 1999, 129:243S-246S.","journal-title":"J Nutr"},{"key":"23_CR35","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1006\/gyno.1997.4726","volume":"66","author":"C Tempfer","year":"1997","unstructured":"Tempfer C, Zeisler H, Sliutz G, et al.: Serum evaluation of interleukin 6 in ovarian cancer patients. Gynecol Oncol 1997, 66:27\u201330.","journal-title":"Gynecol Oncol"},{"key":"23_CR36","first-page":"2776","volume":"56","author":"M Oka","year":"1996","unstructured":"Oka M, Yamamoto K, Takahashi M, et al.: Relationship between serum levels of interleukin 6, various disease parameters and malnutrition in patients with esophageal squamous cell carcinoma. Cancer Res 1996, 56:2776\u20132780.","journal-title":"Cancer Res"},{"key":"23_CR37","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1001\/archsurg.1987.01400240042007","volume":"122","author":"RS Warren","year":"1987","unstructured":"Warren RS, Starnes HF Jr, Gabrilove JL, et al.: The acute metabolic effects of tumor necrosis factor administration in humans. Arch Surg 1987, 122:1396\u20131400.","journal-title":"Arch Surg"},{"key":"23_CR38","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1080\/01635589809514687","volume":"31","author":"DC McMillan","year":"1998","unstructured":"McMillan DC, Scott HR, Watson WS, et al.: Longitudinal study of body cell mass depletion and the inflammatory response in cancer patients. Nutr Cancer 1998, 31:101\u2013105.","journal-title":"Nutr Cancer"},{"key":"23_CR39","first-page":"575","volume":"38","author":"K Kato","year":"2000","unstructured":"Kato K, Hitsuda Y, Kawasaki Y, et al.: The value of serum C-reactive protein as a survival determinant in patients with advanced non-small-cell lung cancer. Nihon Kokyuki Gakkai Zasshi 2000, 38:575\u2013580.","journal-title":"Nihon Kokyuki Gakkai Zasshi"},{"key":"23_CR40","first-page":"1417","volume":"91","author":"CW Wu","year":"1996","unstructured":"Wu CW, Wang SR, Chao MF, et al.: Serum interleukin-6 levels reflect disease status of gastric cancer. Am J Gastroenterol 1996, 91:1417\u20131422.","journal-title":"Am J Gastroenterol"},{"key":"23_CR41","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1007\/BF00311770","volume":"26","author":"K Nomura","year":"1996","unstructured":"Nomura K, Noguchi Y, Matsumoto A: Stimulation of decreased lipoprotein lipase activity in the tumor-bearing state by the antihyperlipidemic drug bezafibrate. Surg Today 1996, 26:89\u201394.","journal-title":"Surg Today"},{"key":"23_CR42","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/S0026-0495(98)90201-3","volume":"47","author":"M Ohara","year":"1998","unstructured":"Ohara M, Tsutsumi K, Ohsawa N: Suppression of carcass weight loss in cachexia in rats bearing Leydig cell tumor by the novel compound NO-1886, a lipoprotein lipase activator. Metabolism 1998, 47:101\u2013105.","journal-title":"Metabolism"},{"key":"23_CR43","first-page":"3111","volume":"20","author":"S Tsujimoto","year":"2000","unstructured":"Tsujimoto S, Kawamura I, Inami M, et al.: Cachexia induction by EL-4 lymphoma in mice and possible involvement of impaired lipoprotein lipase activity. Anticancer Res 2000, 20:3111\u20133116.","journal-title":"Anticancer Res"},{"key":"23_CR44","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1111\/j.1365-2141.1995.tb05403.x","volume":"91","author":"T Lavabre-Bertrand","year":"1995","unstructured":"Lavabre-Bertrand T, Exbrayat C, Liautard J, et al.: Detection of membrane and soluble interleukin-6 receptor in lymphoid malignancies. Br J Haematol 1995, 91:871\u2013877.","journal-title":"Br J Haematol"},{"key":"23_CR45","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1111\/j.1365-2249.1995.tb03672.x","volume":"100","author":"A Yokoyama","year":"1995","unstructured":"Yokoyama A, Kohno N, Hirasawa Y, et al.: Evaluation of soluble IL-6 receptor concentration in serum and epithelial lining fluid from patients with interstitial lung diseases. Clin Exp Immunol 1995, 100:325\u2013329.","journal-title":"Clin Exp Immunol"},{"key":"23_CR46","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/0167-5699(94)90137-6","volume":"15","author":"H Baumann","year":"1994","unstructured":"Baumann H, Gauldie J: The acute phase response. Immunol Today 1994, 15:74\u201380.","journal-title":"Immunol Today"},{"key":"23_CR47","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1046\/j.1365-2168.2001.01669.x","volume":"88","author":"SJ Wigmore","year":"2001","unstructured":"Wigmore SJ, McMahon AJ, Sturgeon CM, Fearon KC: Acutephase protein response, survival and tumour recurrence in patients with colorectal cancer. Br J Surg 2001, 88:255\u2013260. s important study investigates the prognostic significance of a preoperative and postoperative acute phase protein response in relation to disease-specific mortality rate.","journal-title":"Br J Surg"},{"key":"23_CR48","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0065-230X(08)60893-3","volume":"30","author":"EH Cooper","year":"1979","unstructured":"Cooper EH, Stone J: Acute phase reactant proteins in cancer. Adv Cancer Res 1979, 30:1\u201344.","journal-title":"Adv Cancer Res"},{"key":"23_CR49","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/S0002-9610(99)80296-7","volume":"170","author":"DC McMillan","year":"1995","unstructured":"McMillan DC, Wotherspoon HA, Fearon KC, et al.: A prospective study of tumor recurrence and the acute-phase response after apparently curative colorectal cancer surgery. Am J Surg 1995, 170:319\u2013322.","journal-title":"Am J Surg"},{"key":"23_CR50","doi-asserted-by":"crossref","first-page":"1934","DOI":"10.1016\/S0022-5347(05)68072-X","volume":"162","author":"K Fujikawa","year":"1999","unstructured":"Fujikawa K, Matsui Y, Oka H, et al.: Serum C-reactive protein level and the impact of cytoreductive surgery in patients with metastatic renal cell carcinoma. J Urol 1999, 162:1934\u20131937.","journal-title":"J Urol"},{"key":"23_CR51","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1200\/JCO.1996.14.1.171","volume":"14","author":"S Earlam","year":"1996","unstructured":"Earlam S, Glover C, Fordy C, et al.: Relation between tumor size, quality of life, and survival in patients with colorectal liver metastases. J Clin Oncol 1996, 14:171\u2013175.","journal-title":"J Clin Oncol"},{"key":"23_CR52","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/S0748-7983(96)92398-7","volume":"22","author":"J Goransson","year":"1996","unstructured":"Goransson J, Jonsson S, Lasson A: Pre-operative plasma levels of C-reactive protein, albumin and various plasma protease inhibitors for the pre-operative assessment of operability and recurrence in cancer surgery. Eur J Surg Oncol 1996, 22:607\u2013617.","journal-title":"Eur J Surg Oncol"},{"key":"23_CR53","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1111\/j.1365-2141.1995.tb08407.x","volume":"89","author":"S Steinshamn","year":"1995","unstructured":"Steinshamn S, Brekke OL, Waage A: Soluble tumour necrosis factor receptors, tumour necrosis factor and interleukin-6 in serum in granulocytopenic patients with fever. Br J Haematol 1995, 89:719\u2013724.","journal-title":"Br J Haematol"},{"key":"23_CR54","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1007\/s005200000181","volume":"9","author":"R Kallio","year":"2001","unstructured":"Kallio R, Bloigu A, Surcel HM, Syrjala H: C-reactive protein and erythrocyte sedimentation rate in differential diagnosis between infections and neoplastic fever in patients with solid tumours and lymphomas. Support Care Cancer 2001, 9:124\u2013128.","journal-title":"Support Care Cancer"},{"key":"23_CR55","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1093\/infdis\/165.5.886","volume":"165","author":"D Heney","year":"1992","unstructured":"Heney D, Lewis IJ, Evans SW, et al.: Interleukin-6 and its relationship to C-reactive protein and fever in children with febrile neutropenia. J Infect Dis 1992, 165:886\u2013890.","journal-title":"J Infect Dis"},{"key":"23_CR56","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1006\/gyno.1995.1041","volume":"56","author":"K Economos","year":"1995","unstructured":"Economos K, Lucci JAIII, Richardson B, et al.: The effect of naproxen on fever in patients with advanced gynecologic malignancies. Gynecol Oncol 1995, 56:250\u2013254.","journal-title":"Gynecol Oncol"},{"key":"23_CR57","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1159\/000012186","volume":"59","author":"H Ueno","year":"2000","unstructured":"Ueno H, Okada S, Okusaka T, et al.: Prognostic factors in patients with metastatic pancreatic adenocarcinoma receiving systemic chemotherapy. Oncology 2000, 59:296\u2013301.","journal-title":"Oncology"}],"container-title":["Current Oncology Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11912-002-0023-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11912-002-0023-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11912-002-0023-1","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,4,22]],"date-time":"2020-04-22T16:49:16Z","timestamp":1587574156000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11912-002-0023-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2002,6]]},"references-count":57,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2002,6]]}},"alternative-id":["23"],"URL":"https:\/\/doi.org\/10.1007\/s11912-002-0023-1","relation":{},"ISSN":["1523-3790","1534-6269"],"issn-type":[{"value":"1523-3790","type":"print"},{"value":"1534-6269","type":"electronic"}],"subject":[],"published":{"date-parts":[[2002,6]]}}}